Descrizione Clinica
GLYCERIN SUPPLEMENTS ADULT USE 2250 MG SUPPLEMENTS
active ingredients
Each suppository contains: active ingredient: glycerol 2250 mg For the complete list of excipients, see paragraph 6.1.Excellent
Sodium stearate, sodium carbonate anidro.Therapeutic indications
Short-term treatment of occasional constipation.Contraindications
Hypersensitivity to the active ingredient or any of the excipients listed in paragraph 6.1. Laxatives are contraindicated in subjects with acute or unknown abdominal pain, nausea or vomiting, obstruction or intestinal stenosis, rectal bleeding of unknown origin, severe state of dehydration.Population
1 supposes when necessary or second prescription. The correct dose is sufficient to produce an easy evacuation of soft feces. It is advisable to initially use the minimum doses provided. When necessary, the dose may be increased, but never exceed the maximum indicated. A fluid-rich diet promotes the effect of the medicine. Preferably in the evening. Laxatives must be used as frequently as possible and for no more than seven days. Use for longer periods of time requires the doctor’s prescription after adequate evaluation of the individual case.Conservation
This medicine does not require any special condition of conservation.Warnings
If the suppositories were less consistent than they had to, dip the containers before opening them in cold water. Continuous use of laxatives can result in a different type of addiction or damage. Warnings Laxative abuse (frequent or prolonged use or excessive doses) can cause persistent diarrhea resulting in water loss, mineral salts (especially potassium) and other essential nutrients. In the most serious cases, dehydration or hypopotassiemia may occur, which may result in cardiac or neuromuscular dysfunctions, especially in the case of contemporary treatment with cardiac glycosides, diuretics or corticosteroids. The abuse of laxatives, especially those of contact (stimulating laxatives), can cause dependence (and, therefore, possible need to gradually increase the dosage), chronic constipation and loss of normal intestinal functions (intestinal atonia). Precautions for use In children under 12 years, the medicine can only be used after consulting the doctor. Treatment of chronic or recurring constipation always requires medical intervention for diagnosis, prescription of drugs and surveillance during therapy. Consult your doctor when the need for laxative comes from a sudden change of previous intestinal habits (frequency and evacuation characteristics) that lasts for more than two weeks or when the use of laxative fails to produce effects. You should also consult your doctor before using the medicine.Interactions
Milk or antacids may change the effect of the medicinal product; let spend a range of at least an hour before taking the laxative. Laxatives can reduce the time of stay in the intestine, and therefore the absorption, of other drugs administered simultaneously orally. Avoid taking laxatives and other drugs at the same time: after taking a medicine let spend a range of at least 2 hours before taking laxative.Effects
Occasionally: isolated crampiform pain or abdominal colic pain, more frequent in cases of severe constipation. Reporting of suspicious adverse reactions The reporting of suspicious adverse reactions that occur after the authorization of the medicinal product is important, as it allows continuous monitoring of the benefit/risk ratio of the medicinal product. Healthcare workers are required to report any suspected adverse reaction via the national reporting system at the address http://www.agenziafarmaco.gov.it/it/responsabili.Overdosing
Excessive doses can cause abdominal pain and diarrhea; the consequent losses of liquids and electrolytes must be replaced. See also the paragraph "Special warnings and precautions of use" about the abuse of laxatives.There are no adequate and well-controlled studies on the use of pregnant or nursing medicine. Therefore the medicinal product must be used only in case of need, under the direct control of the doctor, after evaluating the expected benefit for the mother in relation to the possible risk for the fetus or for the infant.
Source: Farmadati